Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care

Author(s): Honoré C, Méeus P, Stoeckle E, Bonvalot S


Four thousand new cases of soft tissue sarcomas are diagnosed each year in France, 23% of which are localized in the abdomen and pelvis; the treatment of non-metastatic tumor is based on wide surgical resection, the quality of which determines the long-term outcome. To ensure appropriate care, the European Society of Medical Oncology (ESMO) recommends that any patient with an unexplained soft tissue mass (of any size for deep lesions or of >5 cm for superficial lesions) be referred to a specialized center with capacities for multidisciplinary team decision; appropriate imaging should be performed prior to treatment and a percutaneous image-guided needle biopsy should be routinely performed. In France, clinical and pathology networks (NetSarc and RRePS) currently offer patients a structured means to make a systematic diagnosis of soft tissue sarcoma and help to provide access to appropriate treatment in a specialized center.

Similar Articles

Giant liposarcoma of the omentum mimicking an ovarian tumor

Author(s): Mehdi S, Jalil M, Said B, Mohammed KL, Rahal M, et al.

Liver resection for metastatic soft tissue sarcoma: an analysis of prognostic factors

Author(s): Marudanayagam R, Sandhu B, Perera MT, Bramhall SR, Mayer D

Primary liposarcoma of the omentum

Author(s): Okajima Y, Nishikawa M, Ohi M, Fukumoto Y, Kuroda K, et al.

Prognostic factors in adult patients with locally controlled soft tissue sarcoma

Author(s): Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, et al.

Prognosis of lymph node metastasis in soft tissue sarcoma

Author(s): Behranwala KA, A’Hern R, Omar AM, Thomas JM

Biologiemoléculaire des sarcomes et choixthérapeutiques

Author(s): Dufresne A, Cassier P, Heudel P, Pissaloux D, Wang Q, et al.